Skip to main content Skip to main navigation menu Skip to site footer

Caspase-3 Expression Correlation with Cell Differentiation Grade, Stage, and Residual Tumor Size in Epithelial Ovarian Cancer

  • I Nyoman Gede Budiana ,


Abstract

Objective: Ovarian cancer has a high incidence and a high mortality rate, and often found in terminal stage. In ovarian malignancy, one of the important proteins presents in the apoptosis process is Caspase-3. Caspase-3 has an important role in modifying the cell morphologic and several biochemistry condition of the apoptosis process. Our study aims to analyze the correlation between Caspase-3 expression and the cell differentiation grade, the stage of the disease, and the residual tumor size after primary surgery in epithelial ovarian cancer. Method: We conducted a cross-sectional study. The sample was recruited in Dr. Soetomo Hospital Surabaya. They were ovarian cancer patients with complete medical records, which ovarian tumor specimens were deparaffinized in the pathology anatomy laboratory, Faculty of Medicine, Airlangga University, Surabaya, Indonesia. Patients who received a chemotherapy or a radiotherapy before the surgery, or whose paraffin wax embedded tissue was damaged were excluded. The Caspase-3 expression was examined immunohistochemically. The correlation among the variables were analysed using the Spearman and Phi correlation test. Results: From 42 patients, Caspase-3 expression was positive in the 47.6%, while the 52.4% was negative. It was found that most samples with a good grade of cell differentiation showed a positive Caspase-3 expression (r=-0.215, p<0.05). Moreover, in most samples with the early stage of the disease had a positive Caspase-3 expression (φ=-0.583, p<0.05). In addition, most samples with residual tumor less than 1 cm in diameter, also showed a positive Caspase-3 expression (φ=-0.336, p=0.029). Conclusion: A statistically significant negative correlation was present between Caspase-3 expression and the cell differentiation grade, the stage of the disease, and the residual tumor after the primary surgery.

Keywords: Caspase-3 grade of cell differentiation stage of disease residual tumor

References

  1. Ferlay, J., Shin, H.,R., Bray, F., Forman, D., Mathers, C., Parkin, D.,M. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International Journal of Cancer 2010;127:2893-917.
  2. Jemal, A., Bray, F., Center, M.,M., Ferlay, J., Ward, E., Forman, D. Global cancer statistics. CA Cancer J Clin 2011;61(2):69-90.
  3. Aziz, M.,F. Gynecological cancer in Indonesia. J Gynecol Oncol 2009;20(1-8):8-10.
  4. Karyana, K. Profil penderita kanker ovarium di RS Sanglah Denpasar [tesis]. Denpasar: Bag/SMF Obstetri dan Ginekologi FK UNUD/RS Sanglah Denpasar; 2005.
  5. The American College of Obstetricians and Gynecologist. The role of the Obstetrician-Gynecologist in the early detection of epithelial ovarian cancer. Committee Opinion number 477. March 2011:1-5.
  6. Diaz-Montes, T.,P., Bristow, R. Clinical predictors of outcome in epithelial ovarian carcinoma. Dalam: Levenback, C.,F., Sood, A.,K., Lu, K.,H., Coleman, R.,L., penyunting. Prognostic and predictive factors in gynecologic cancers. United Kingdom: Informa Healthcare; 2007. p.3-11.
  7. Vranic, A. Caspase-3 and survivin expression in primary atypical and malignant meningiomas. ISRN Neuroscience 2013;2013:1-5.
  8. Yang, C., Ionescu-Tiba, V., Burns, K., dkk. The role of the cyclin D1-dependent kinases in ErbB2-mediated breast cancer. American Journal of Pathology 2004;164(3):1031-8.
  9. Fan, T.,J., Han, L.,H., Ceng, R.,S., Liang, J. Caspase family proteases and apoptosis. Acta Biochimica et Biophysica Sinica 2005;37(11):719-27.
  10. Vang, R., Shih, I.,M., Kurman, R.,J. Ovarian low-grade and high-grade serous carcinoma: pathogenesis, clinicopathologic, and molecular biologic features and diagnostic problems. Adv Anat Pathol 2009;16:267-82.
  11. Tavassoli, F.,A., Devilee, P. Tumours of the Breast and Female Genital Organs. World Health Organization Classification of Tumors. Lyon, France: IARC Press; 2003. p.114.
  12. Shimizu, Y., Kamoi, S., Amada, S., Akiyama, F., Silverberg, S.,G. Toward the development of a universal grading system for ovarian epithelial carcinoma: testing of a proposed in a series of 461 patients with uniform treatment and follow-up. Cancer 1998;82:893-901.
  13. ???
  14. Wilailak, S. Epidemiologic report of gynecological cancer in Thailand. J Gynecol Oncol 2009;20(2):80-3.
  15. Whittemore, A.,S., Harris, R., Itnyre, J. Collaborative ovarian cancer group: characteristics relating to ovarian cancer risk, collaborative analysis of 12 US case-control studies.II.invasive epithelial ovarian cancer in white women. Am J Epidemiol 1992;136(10):1212-20.
  16. Yancik, R., Ries, L.,G., Yates, J.,W. Ovarian cancer in the elderly: an analysis of Surveillance, Epidemiology, and End Results Program data. Am J Obstet Gynecol 1986;154(3):639-47.
  17. Rivas-Corchado, L.,M., Gonzales-Geroniz, M., Hernandez-Herrera, R.,J. Epidemiological profile of ovarian cancer. Ginecol Obstet Mex 2011;79(9):558-64.
  18. Pelucchi, C., Galeone, C., Talamin, R., dkk. Lifetime ovulatory cycles and ovarian cancer risk in two Italian case-control studies. Am J Obstet Gynecol 2007;196(1):831-7.
  19. Scully, R.,E., Young, R., Clemet, P.,B. Tumor of the ovary, maldeveloped gonad, and broad ligament. Dalam: Atlas of tumor pathology. 3rd series, fascicle 23. Washington DC: Armed Forces Institute of pathology; 1998. p.51-168.
  20. Hoskin, W.,J., McGuire, W., Brady, M.,F., dkk. The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma. Am J Obstet Gynecol 1994;170:974-80.
  21. Sorbe, B., Frankendal, B., Veress, B. Importance of histologic grading in the prognosis of epithelial ovarian carcinoma. Obstet Gynecol 1982;59(5):576-82.
  22. Zheng, Q-Q., Wong, P., Hui, R., Yao, A-M. Prognostic analysis of ovarian cancer patients using the Cox regression model. Chinese Journal of Cancer 2009;28(2):170-2.
  23. The American College of Obstetricians and Gynecologist. The role of the generalist Obstetrician-Gynecologist in the early detection of ovarian cancer. Committee Opinion number 280. 2002:1-5.
  24. Polterauer, S., Vergote, I., Concin, N., dkk. Prognostic value of residual tumor size in patients with epithelial ovarian cancer FIGO stages IIA-IV: analysis of the OVCAD data. Int J Gynecol Cancer 2012;22(3):380-5.
  25. Duo, Y., Tong, L. Expression of Caspase-3 and Bcl-2 Protein in Epithelial Ovarian Tumor and Relation of The Expression with Cell Apoptosis and Proliferation. China Journal of Modern Medicine 2004;8:8-15.
  26. Porter, A.,G., Janicke, R.,U. Emerging roles of Caspase-3 in apoptosis. Cell Death and Differentiation 1999;6:99-104.
  27. Rastogi, R.,P., Richa, Sinha, R.,P. Apoptosis: Molecular mechanisms and pathogenicity. EXCLI Journal 2009;8:155-81.
  28. Wei, C., Ping, P. Expression and clinical significance of xiap and Caspase-3 protein in primary epithelia ovarian cancer. Chinese Journal of Cellular and Molecular Immunology 2010;7:7-16.
  29. Wakabayashi, M.,T., Lin, P.,S., Hakim, A.,A. The role of cytoreductive/debulking surgery in ovarian cancer. J Natl Compr Canc Netw 2008;6(8):803-10.
  30. Manipalviratn, S., Worasethsin, P., Triratanachat, S., Tresukosol, D. Impact of residual tumor on survival of patients with advanced stage common epithelial ovarian cancer at King Chulalongkorn Memorial Hospital from 1995 to 1999. Thai Journal of Obstetrics and Gynaecology 2002;14:269-76.
  31. Winter III, W.,E., Maxwell, L., Tian, C., dkk. Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: A Gynecologic Oncologic Group Study. J Clin Oncol 2008;26(1):83-9.
  32. Fan, T.,J., Han, L.,H., Ceng, R.,S., Liang, J. Caspase family proteases and apoptosis. Acta Biochimica et Biophysica Sinica 2005;37(11):719-27.

How to Cite

Budiana, I. N. G. (2016). Caspase-3 Expression Correlation with Cell Differentiation Grade, Stage, and Residual Tumor Size in Epithelial Ovarian Cancer. Bali Medical Journal, 5(2), 335–339. https://doi.org/10.15562/bmj.v5i2.259
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver
Download Citation
Endnote/Zotero/Mendeley (RIS) BibTeX

HTML
3

Total
3

Share

Search Panel

I Nyoman Gede Budiana
Google Scholar
Pubmed
BMJ Journal